ASTERDM (Aster DM Healthcare Ltd.): Acquisition / M&A
Aster DM Healthcare informed the National Stock Exchange that the Effective Date of its Scheme of Amalgamation has been triggered, alongside a change in promoter category and amended Memorandum and Articles of Association, according to the exchange filing dated 1 July 2026. This follows a series of related announcements through late June, including board meetings noting the NCLT order and fixation of record date, as well as multiple disclosures about the acquisition of Optionally Convertible Redeemable Preference Shares in an associate company.
Events like this — acquisition or M&A announcements — have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213%. This base rate describes past patterns for this event type broadly, not a forecast for Aster DM specifically.
The stock closed at ₹776.0 on 1 July, down 1.08% from the previous session, against a Nifty gain of 0.59%. It trades 6.22% below its 52-week high of ₹836.5 and 51.12% above its 52-week low of ₹519.1. Relative volume stood at 1.11, with the RSI at 55.7. The shares remain above both their 50-day and 200-day simple moving averages. Valuation metrics show a price-to-earnings ratio of 120.68 and price-to-book of 8.74, with return on equity at 10.1%.
The filing confirms the corporate restructuring has reached its effective date. What it does not establish is whether the market will re-rate the stock, how the preference share acquisition will affect consolidated financials, or whether current valuations already reflect these developments.
The catalyst
Aster DM Healthcare Limited has informed the Exchange regarding Effective Date of the Scheme, Change in Promoter category and Amended MoA & AOA of the Company pursuant to the Scheme of Amalgamation. (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.
ASTERDM right now
trading -1.08% on the day; P/E 120.68; RSI 55.7. Full ASTERDM analysis →
Sources
- Aster DM Healthcare Limited has informed the Exchange regarding Effective Date of the Scheme, Change in Promoter category and Amended MoA & AOA of the Company pursuant to the Scheme of Amalgamation. — NSE
- Price to sales forward of Aster DM Healthcare Ltd. – NSE:ASTERDM — TradingView
- Aster DM Healthcare Ltd. Actuals & Estimates (NSE:ASTERDM) — TradingView
- Aurobindo Pharma Ltd leads losers in 'A' group — Business Standard
- How The Aster DM Healthcare (NSEI:ASTERDM) Narrative Is Shifting With New Valuation Assumptions — Simply Wall St.
Keep digging
- ASTERDM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.